Classes | Virtual Medical Academy

Viewing 15 results

You are viewing the category of Diabetes

Diabetes

SURMOUNT-5 Clinical Update–Now Published

By :

Carel W Le Roux

Diabetes

Bridging pathophysiology and epidemiology for better understanding of obesity

By :

Dr. Georgios K Dimitriadis

Diabetes

Introducing Mounjaro: A Once-Weekly, First-in-Class GIP and GLP-1 Receptor Agonist

By :

Lilly Saudi Arabia

Diabetes

Supporting Patients with Obesity Through Comprehensive Treatment

By :

Prof.W.Timothy Garvey

Diabetes

Proposed actions of GIP and GLP1 receptor agonist in human

By :

Prof.Rachel Batterham

Diabetes

Potential Impact of Weight Reduction on Obesity-Related Complications

By :

Prof.W.Timothy Garvey

Diabetes

Obesity in Adults: A clinical Practice Guideline

By :

Prof.Rachel Batterham

Diabetes

The Relationship Between Fat Cell Dysfunction and Obesity-Related Complications

By :

Prof.luc Van Gaal

Diabetes

How the Body Resists Weight Reduction

By :

Prof.luc Van Gaal

Diabetes

Addressing Excess Weight In Support of Glycemic Control In Type 2 DM Patients 4

By :

Dr.Rachel Batterham

Diabetes

Addressing Excess Weight In Support of Glycemic Control In Type 2 DM Patients 3

By :

Dr.Matthias Bluher,MD

Diabetes

Addressing Excess Weight In Support of Glycemic Control In Type 2 DM Patients 2

By :

Dr.Tarek M.Fiad

About Us

Support

Technical Requirements

VMA Team

Partner

You are viewing the category of Diabetes

SURMOUNT-5 Clinical Update–Now Published

Bridging pathophysiology and epidemiology for better understanding of obesity

Introducing Mounjaro: A Once-Weekly, First-in-Class GIP and GLP-1 Receptor Agonist

Supporting Patients with Obesity Through Comprehensive Treatment

Proposed actions of GIP and GLP1 receptor agonist in human

Potential Impact of Weight Reduction on Obesity-Related Complications

Obesity in Adults: A clinical Practice Guideline

The Relationship Between Fat Cell Dysfunction and Obesity-Related Complications

How the Body Resists Weight Reduction

Addressing Excess Weight In Support of Glycemic Control In Type 2 DM Patients 4

Addressing Excess Weight In Support of Glycemic Control In Type 2 DM Patients 3

Addressing Excess Weight In Support of Glycemic Control In Type 2 DM Patients 2

Call Center 920008161

[email protected]